The Structural Basis of Viral RNA Sensing by the RIG-I Like Receptors

RIG-I 样受体感知病毒 RNA 的结构基础

基本信息

  • 批准号:
    8060538
  • 负责人:
  • 金额:
    $ 32.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-04-15 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Innate immune responses provide the first line of defense against invading pathogens through the recognition of pathogen associated molecular patterns. The RIG-I like receptors (RLRs), RIG-I, MDA5 and LGP2, are cytosolic sensors of viral RNA and play pivotal roles in innate antiviral immune responses. The RLRs recognize 5' triphosphate single-stranded RNA or double-stranded RNA, signature structures of viral RNA. Stimulation of the RLRs by viral RNA leads to the induction of type I interferons and other cytokines, conferring antiviral activity to the host and activating the acquired immune responses. However, the detailed mechanisms of viral RNA sensing and signaling by the RLRs are still not fully understood. It is not clear what are the structural features of viral RNA recognized by the RLRs and how the RLRs recognize viral RNA at molecular level. The mechanisms of RLRs activation by viral RNA are still largely unknown. The proposed research will focus on elucidating the structural basis of viral RNA sensing by the RLRs with the following specific aims: 1) determine the structural features of RNA recognized by the RLRs; 2) elucidate the structural basis of RNA recognition by the RLRs; 3) investigate the molecular mechanism of RLRs activation by RNA. This research represents a vigorous and comprehensive investigation of the structural basis for viral RNA sensing by the RLRs through a combined approach of biochemical, structural, and functional studies. These studies will provide important insights into the molecular mechanism of viral RNA sensing by the RLRs. This research will significantly advance our understanding about the mechanisms of antiviral immune response mediated by the RLRs and provide a structural framework for the development of more effective adjuvant for vaccines and novel therapeutic reagents to modulate the antiviral immune responses. PUBLIC HEALTH RELEVANCE: In this research, we will elucidate how our immune system responds to viral infections through studying the molecular structures of key proteins sensing the viral nucleic acids. These studies will lead to the fundamental understanding about the molecular mechanism of antiviral immunity and will also provide critical information for potential therapeutic interventions.
描述(由申请方提供):先天免疫应答通过识别病原体相关分子模式提供抵抗入侵病原体的第一道防线。RIG-I样受体(RIG-I like receptor,RLR),RIG-I、MDA 5和LGP 2是病毒RNA的胞质传感器,并且在先天性抗病毒免疫应答中起关键作用。RLR识别5'三磷酸单链RNA或双链RNA,病毒RNA的特征结构。病毒RNA刺激RLR导致I型干扰素和其他细胞因子的诱导,赋予宿主抗病毒活性并激活获得性免疫应答。然而,通过RLR的病毒RNA传感和信号传导的详细机制仍然没有完全理解。目前还不清楚RLR识别的病毒RNA的结构特征以及RLR如何在分子水平上识别病毒RNA。病毒RNA激活RLR的机制在很大程度上仍然是未知的。本论文的主要研究内容包括:1)确定RLR识别RNA的结构特征; 2)阐明RLR识别RNA的结构基础; 3)研究RLR激活RNA的分子机制。这项研究代表了一个强有力的和全面的调查的结构基础,通过生物化学,结构和功能的研究相结合的方法,通过RLRs的病毒RNA传感。这些研究将提供重要的见解病毒RNA传感的分子机制的RLRs。本研究将显著提高我们对RLR介导的抗病毒免疫应答机制的理解,并为开发更有效的疫苗佐剂和新型治疗试剂以调节抗病毒免疫应答提供结构框架。 公共卫生关系:在这项研究中,我们将阐明我们的免疫系统如何通过研究病毒核酸的关键蛋白质的分子结构来应对病毒感染。这些研究将导致对抗病毒免疫的分子机制的基本理解,也将为潜在的治疗干预提供关键信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pingwei Li其他文献

Pingwei Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pingwei Li', 18)}}的其他基金

Molecular basis of viral DNA sensing through the cGAS-STING pathway
通过 cGAS-STING 途径检测病毒 DNA 的分子基础
  • 批准号:
    10549776
  • 财政年份:
    2019
  • 资助金额:
    $ 32.27万
  • 项目类别:
The Structural Basis of Viral RNA Sensing by the RIG-I Like Receptors
RIG-I 样受体感知病毒 RNA 的结构基础
  • 批准号:
    7860417
  • 财政年份:
    2010
  • 资助金额:
    $ 32.27万
  • 项目类别:
The Structural Basis of Viral RNA Sensing by the RIG-I Like Receptors
RIG-I 样受体感知病毒 RNA 的结构基础
  • 批准号:
    8441587
  • 财政年份:
    2010
  • 资助金额:
    $ 32.27万
  • 项目类别:
The Structural Basis of Viral RNA Sensing by the RIG-I Like Receptors
RIG-I 样受体感知病毒 RNA 的结构基础
  • 批准号:
    8239458
  • 财政年份:
    2010
  • 资助金额:
    $ 32.27万
  • 项目类别:
The Structural Basis of Viral RNA Sensing by the RIG-I Like Receptors
RIG-I 样受体感知病毒 RNA 的结构基础
  • 批准号:
    8637904
  • 财政年份:
    2010
  • 资助金额:
    $ 32.27万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 32.27万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 32.27万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 32.27万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 32.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 32.27万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 32.27万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 32.27万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 32.27万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 32.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 32.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了